FinTrust Capital Advisors’s Biogen BIIB Stock Holding History

FinTrust Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$81.2K	Buy	419 +12	+3%	+$2.51K	0.01%	474
2024 Q2	$94.4K	Buy	407 +83	+26%	+$18K	0.02%	411
2024 Q1	$69.9K	Sell	324 -55	-15%	-$12.9K	0.01%	447
2023 Q4	$98.1K	Sell	379 -68	-15%	-$16.7K	0.02%	371
2023 Q3	$115K	Buy	447 +406	+990%	+$109K	0.03%	316
2023 Q2	$11.4K	Hold	41	–	–	﹤0.01%	746
2023 Q1	$11.4K	Hold	41	–	–	﹤0.01%	744
2022 Q4	$11.4K	Hold	41	–	–	﹤0.01%	741
2022 Q3	$11K	Hold	41	–	–	﹤0.01%	843
2022 Q2	$8K	Buy	41 +28	+215%	+$5.72K	﹤0.01%	937
2022 Q1	$3K	Hold	13	–	–	﹤0.01%	1112
2021 Q4	$3K	Hold	13	–	–	﹤0.01%	1071
2021 Q3	$4K	Hold	13	–	–	﹤0.01%	1040
2021 Q2	$5K	Hold	13	–	–	﹤0.01%	1039
2021 Q1	$4K	Hold	13	–	–	﹤0.01%	1038
2020 Q4	$3K	Sell	13 -133	-91%	-$34.3K	﹤0.01%	989
2020 Q3	$41K	Sell	146 -216	-60%	-$60.2K	0.01%	526
2020 Q2	$97K	Sell	362 -258	-42%	-$77.6K	0.04%	339
2020 Q1	$196K	Buy	620 +182	+42%	+$55.2K	0.09%	181
2019 Q4	$130K	Buy	438 +100	+30%	+$27.7K	0.05%	290
2019 Q3	$79K	Buy	338 +91	+37%	+$21.2K	0.03%	371
2019 Q2	$58K	Sell	247 -32	-11%	-$7.39K	0.02%	380
2019 Q1	$66K	Sell	279 -9	-3%	-$2.83K	0.03%	341
2018 Q4	$87K	Buy	+288	New	+$91.9K	0.04%	284

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FinTrust Capital Advisors's BIIB Position: Q3 2024 in Review

FinTrust Capital Advisors increased its Biogen (BIIB) stake by 2.9% in Q3 2024, buying an estimated $2.51K and bringing the position to 419 shares worth $81.2K. The position accounts for 0.01% of the portfolio, ranked #474.

FinTrust Capital Advisors first reported a position in BIIB in Q4 2018 and has held it in 24 quarters since. The position peaked at $196K in Q1 2020. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

FinTrust Capital Advisors held 419 shares of Biogen worth $81.2K as of Q3 2024.
FinTrust Capital Advisors bought 12 Biogen shares in Q3 2024, an estimated $2.51K.
Biogen made up 0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #474 holding.
FinTrust Capital Advisors first reported a position in Biogen in Q4 2018 and has held it in 24 quarters since.
FinTrust Capital Advisors's Biogen position peaked at $196K in Q1 2020.
917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.